Can the Results of the European Randomized Study of Screening for Prostate Cancer Be Decontaminated?

被引：1
|
作者：
Metcalfe, Chris [1 ]
机构：
[1] Univ Bristol, Sch Social & Community Med, Bristol BS8 2PS, Avon, England
来源：
EUROPEAN UROLOGY | 2014年 / 65卷 / 02期
关键词：
D O I：
10.1016/j.eururo.2013.08.058
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：337 / 338
页数：2
相关论文
共 50 条
  • [31] Screening and Prostate-Cancer Mortality in a Randomized European Study Editorial Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2009, 182 (01): : 145 - 146
  • [32] Screening for prostate cancer without digital rectal examination and transrectal ultrasound:: Results after four years in the European Randomized Study of Screening for Prostate Cancer (ERSPC), Rotterdam
    Gosselaar, C
    Roobol, MJ
    Roemeling, S
    de Vries, SH
    van der Cruijsen-Koeter, I
    van der Kwast, TH
    Schröder, FH
    PROSTATE, 2006, 66 (06): : 625 - 631
  • [33] Absolute Effect of Prostate Cancer Screening: Balance of Benefits and Harms by Center within the European Randomized Study of Prostate Cancer Screening
    Auvinen, Anssi
    Moss, Sue M.
    Tammela, Teuvo L. J.
    Taari, Kimmo
    Roobol, Monique J.
    Schroder, Fritz H.
    Bangma, Chris H.
    Carlsson, Sigrid
    Aus, Gunnar
    Zappa, Marco
    Puliti, Donella
    Denis, Louis J.
    Nelen, Vera
    Kwiatkowski, Maciej
    Randazzo, Marco
    Paez, Alvaro
    Lujan, Marcos
    Hugosson, Jonas
    CLINICAL CANCER RESEARCH, 2016, 22 (01) : 243 - 249
  • [34] Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer
    Walter, S. D.
    Hu, Jiarui
    Talala, Kirsi
    Tammela, Teuvo
    Taari, Kimmo
    Auvinen, Anssi
    CANCER CAUSES & CONTROL, 2021, 32 (11) : 1299 - 1313
  • [35] Estimating the rate of overdiagnosis with prostate cancer screening: evidence from the Finnish component of the European Randomized Study of Screening for Prostate Cancer
    S. D. Walter
    Jiarui Hu
    Kirsi Talala
    Teuvo Tammela
    Kimmo Taari
    Anssi Auvinen
    Cancer Causes & Control, 2021, 32 : 1299 - 1313
  • [36] Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)
    Beemsterboer, PMM
    Kranse, R
    de Koning, HJ
    Habbema, JDF
    Schröder, FH
    INTERNATIONAL JOURNAL OF CANCER, 1999, 84 (04) : 437 - 441
  • [37] A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Goteborg, Sweden
    Vickers, Andrew J.
    Cronin, Angel M.
    Aus, Gunnar
    Pihl, Carl-Gustav
    Becker, Charlotte
    Pettersson, Kim
    Scardino, Peter T.
    Hugosson, Jonas
    Lilja, Hans
    BMC MEDICINE, 2008, 6 (1)
  • [38] Prostate specific antigen testing and digital rectal examination before and during a randomized trial of screening for prostate cancer:: European randomized study of screening for prostate cancer, Rotterdam
    Beemsterboer, PMM
    de Koning, HJ
    Kranse, R
    Trienekens, PH
    van der Maas, PJ
    Schröder, FH
    JOURNAL OF UROLOGY, 2000, 164 (04): : 1216 - 1220
  • [39] Is Prostate-Specific Antigen Velocity Selective for Clinically Significant Prostate Cancer in Screening? European Randomized Study of Screening for Prostate Cancer (Rotterdam)
    Wolters, Tineke
    Roobol, Monique J.
    Bangma, Chris H.
    Schroder, Fritz H.
    EUROPEAN UROLOGY, 2009, 55 (02) : 385 - 393
  • [40] Results and participation factors to the European Randomized study of Screening for Prostate Cancer (ERSPC) with Prostate Specific Antigen: French departments of Tarn and Herault
    Jegu, J.
    Tretarre, B.
    Grosclaude, P.
    Rebillard, X.
    Bataille, V.
    Malavaud, B.
    Iborra, F.
    Salama, G.
    Rischmann, P.
    Villers, A.
    PROGRES EN UROLOGIE, 2009, 19 (07): : 487 - 498
12345